Forget the short-seller distractions—HPQ is sitting on a ticking regulatory and legal time bomb.
Here’s what matters:
Undisclosed €180K Equity Liability: A binding 3-year service contract obligates HPQ to issue €60,000 annually in shares (~1.47 million total). Zero delivery. Zero disclosure in 2023 & 2024 audits, despite accountant warnings. (IG: IFRS IAS 32/IAS 37, Québec Securities Act §§154 & 196, TSX-V Policies 3.1 & 5.3).
Misleading Public Statements: CEO claimed the equity payment was contingent on funding “that never materialized.” That’s flat wrong—per contract terms and prior HPQ materials.
AMF & TSX-V Eyes On HPQ: Formal complaints lodged with AMF, CIRO, IQ, Forvis Mazars (audit) …and Yeah—an active lawsuit in Frankfurt. If the court upholds the contract, financial restatements and trading halts could follow.
Why It Matters Beyond Canada: A German DAX giant like Evonik won’t partner with a litigation-facing Canadian firm sued in Frankfurt am Main . This is a corporate trust issue—on a very public stage.
Spoofing? Maybe. But this? Far more dangerous. The real risk at HPQ isn’t market manipulation—it’s broken governance. And that could cost investors a lot more than a short-term dip.
Market Data 
Markets 
AI
